Extranodal NK/T cell lymphoma in a living donor liver transplant recipient

Ann Hematol. 2017 Jun;96(6):1051-1052. doi: 10.1007/s00277-017-2969-y. Epub 2017 Mar 9.

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
² Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
³ Department of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
⁴ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kurokawa-tky@umin.ac.jp.

PMID: 28280996
DOI: 10.1007/s00277-017-2969-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Allografts
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Asparaginase / administration & dosage
Dexamethasone / administration & dosage
Drug Substitution
Etoposide / administration & dosage
Humans
Ifosfamide / administration & dosage
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Liver Cirrhosis / etiology
Liver Transplantation*
Living Donors
Lymphoma, Extranodal NK-T-Cell / drug therapy
Lymphoma, Extranodal NK-T-Cell / etiology*
Methotrexate / administration & dosage
Methylprednisolone / therapeutic use
Mycophenolic Acid / therapeutic use
Postoperative Complications / drug therapy
Postoperative Complications / etiology*
Remission Induction
Tacrolimus / adverse effects
Tacrolimus / therapeutic use
Transplant Recipients

Substances

Immunosuppressive Agents
Etoposide
Dexamethasone
Asparaginase
Mycophenolic Acid
Ifosfamide
Tacrolimus
Methylprednisolone
Methotrexate